Systems oncology: Towards patient-specific treatment regimes informed by multiscale mathematical modelling

Seminars in Cancer Biology

Volumn 30, Issue , 2015, Pages 13-20

  Powathil, Gibin G ^a   Swat, Maciej ^b   Chaplain, Mark A J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Cell cycle; Chemotherapy; Hybrid multiscale model; Hypoxia; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER THERAPY; CELL CYCLE; CLINICAL PROTOCOL; EXTRACELLULAR SPACE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MATHEMATICAL MODEL; MULTISCALE MATHEMATICAL MODELLING; NONHUMAN; ONCOLOGY; PERSONALIZED MEDICINE; PROBABILITY; QUALITY OF LIFE; REVIEW; SOLID TUMOR; SYSTEMS BIOLOGY; SYSTEMS ONCOLOGY; TREATMENT RESPONSE; TUMOR GENE; TUMOR MICROENVIRONMENT; MORTALITY; NEOPLASMS; PATHOLOGY; PROCEDURES; THEORETICAL MODEL; TRENDS;

HUMANS; MEDICAL ONCOLOGY; MODELS, THEORETICAL; NEOPLASMS; SYSTEMS BIOLOGY;

EID: 84919636142     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.02.003     Document Type: Review

References (60)

1. Byrne H.M., Chaplain M.A. Growth of nonnecrotic tumors in the presence and absence of inhibitors. Math Biosci. 1995, 130(2):151-181.
2. Byrne H.M., Chaplain M.A. Growth of necrotic tumors in the presence and absence of inhibitors. Math Biosci. 1996, 135(2):187-216.
3. Anderson A.R., Chaplain M.A. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol 1998, 60:857-899.
4. McDougall S.R., Anderson A.R., Chaplain M.A. Mathematical modelling of dynamic adaptive tumour-induced angiogenesis: clinical implications and therapeutic targeting strategies. J Theor Biol. 2006, 241(3):564-589.
5. Al-Tameemi M., Chaplain M., d'Onofrio A. Evasion of tumours from the control of the immune system: consequences of brief encounters. Biol Direct. 2012, 7:31.
6. Matzavinos A., Chaplain M.A., Kuznetsov V.A. Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour. Math Med Biol. 2004, 21(1):1-34.
7. Andasari V., Gerisch A., Lolas G., South A.P., Chaplain M.A. Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation. J Math Biol. 2011, 63(1):141-171.
8. Deakin N.E., Chaplain M.A. Mathematical modeling of cancer invasion: the role of membrane-bound matrix metalloproteinases. Front Oncol. 2013, 3:70.
9. Gerisch A., Chaplain M.A. Mathematical modelling of cancer cell invasion of tissue: local and non-local models and the effect of adhesion. J Theor Biol. 2008, 250(4):684-704.
10. Ramis-Conde I., Chaplain M.A., Anderson A.R., Drasdo D. Multi-scale modelling of cancer cell intravasation: the role of cadherins in metastasis. Phys Biol. 2009, 6(1):016008.
11. Ramis-Conde I., Drasdo D., Anderson A.R., Chaplain M.A. Modeling the influence of the E-cadherin-beta-catenin pathway in cancer cell invasion: a multiscale approach. Biophys J. 2008, 95(1):155-165.
12. Macklin P., McDougall S., Anderson A.R., Chaplain M.A., Cristini V., Lowengrub J. Multiscale modelling and nonlinear simulation of vascular tumour growth. J Math Biol. 2009, 58(4-5):765-798.
13. Wu M., Frieboes H.B., McDougall S.R., Chaplain M.A., Cristini V., Lowengrub J. The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems. J Theor Biol. 2013, 320:131-151.
14. Sturrock M., Terry A.J., Xirodimas D.P., Thompson A.M., Chaplain M.A. Spatio-temporal modelling of the Hes1 and p53-Mdm2 intracellular signalling pathways. J Theor Biol. 2011, 273(1):15-31.
15. Sturrock M., Terry A.J., Xirodimas D.P., Thompson A.M., Chaplain M.A. Influence of the nuclear membrane, active transport, and cell shape on the Hes1 and p53-Mdm2 pathways: insights from spatio-temporal modelling. Bull Math Biol. 2012, 74(7):1531-1579.
16. Lowengrub J.S., Frieboes H.B., Jin F., Chuang Y.L., Li X., Macklin P., et al. Nonlinear modelling of cancer: bridging the gap between cells and tumours. Nonlinearity. 2010, 23:R1-R9.
17. Alarcon T., Byrne H.M., Maini P.K. A cellular automaton model for tumour growth in inhomogeneous environment. J Theor Biol. 2003, 225:257-274.
18. Alarcon T., Byrne H.M., Maini P.K. A multiple scale model for tumour growth. Multiscale Model Sim. 2005, 3:440-475.
19. Ribba B., Saut O., Colin T., Bresch D., Grenier E., Boissel J.P. A multiscale mathematical model of avascular tumor growth to investigate the therapeutic benefit of anti-invasive agents. J Theor Biol. 2006, 243(4):532-541.
20. Zhang L., Wang Z., Sagotsky J.A., Deisboeck T.S. Multiscale agent-based cancer modeling. J Math Biol. 2009, 58(4-5):545-559.
21. Deisboeck T.S., Wang Z., Macklin P., Cristini V. Multiscale cancer modeling. Annu Rev Biomed Eng 2011, 13:127-155.
22. Byrne H.M. Dissecting cancer through mathematics: from the cell to the animal model. Nat Rev Cancer 2010, 10:221-230.
23. Billy F., Ribba B., Saut O., Morre-Trouilhet H., Colin T., Bresch D., et al. A pharmacologically based multiscale mathematical model of angiogenesis and its use in investigating the efficacy of a new cancer treatment strategy. J Theor Biol. 2009, 260(4):545-562.
24. Agur Z., Hassin R., Levy S. Optimizing chemotherapy scheduling using local search heuristics. Operations Research 2006, 54(5):829-846.
25. Fister K.R., Panetta J.C. Optimal control applied to cell-cycle-specific cancer chemotherapy. SIAM J Appl Math 2000, 1059-1072.
26. Frieboes H.B., Edgerton M.E., Fruehauf J.P., Rose F.R., Worrall L.K., Gatenby R.A., et al. Prediction of drug response in breast cancer using integrative experimental/computational modeling. Cancer Res 2009, 69:4484-4492.
27. Liu W., Hillen T., Freedman H. A mathematical model for M-phase specific chemotherapy including the G0-phase and immunoresponse. Math Biosci Eng 2007, 4(2):239.
28. Mistry H.B., MacCallum D.E., Jackson R.C., Chaplain M.A., Davidson F.A. Modeling the temporal evolution of the spindle assembly checkpoint and role of Aurora B kinase. Proc Natl Acad Sci USA. 2008, 105(51):20215-20220.
29. Panetta J., Adam J. A mathematical model of cycle-specific chemotherapy. Math Comput Modell 1995, 22(2):67-82.
30. Ribba B., Marron K., Agur Z., Alarcon T., Maini P.K. A mathematical model of Doxorubicin treatment efficacy for non-Hodgkin's lymphoma: investigation of the current protocol through theoretical modelling results. Bull Math Biol. 2005, 67(1):79-99.
31. Enderling H., Anderson A.R., Chaplain M.A., Munro A.J., Vaidya J.S. Mathematical modelling of radiotherapy strategies for early breast cancer. J Theor Biol. 2006, 241(1):158-171.
32. Ribba B., Colin T., Schnell S. A multiscale mathematical model of cancer, and its use in analyzing irradiation therapies. Theor Biol Med Model. 2006, 3:7.
33. Richard M., Kirkby K., Webb R., Kirkby N. A mathematical model of response of cells to radiation. Nucl Instr Meth Phys Res B 2007, 255(1):18-22.
34. Moreira J., Deutsch A. Cellular automaton models of tumor development: a critical review. Adv Complex Syst (ACS). 2002, 5(2):247-267.
35. Gerlee P., Anderson A.R. An evolutionary hybrid cellular automaton model of solid tumour growth. J Theor Biol 2007, 246:583-603.
36. Powathil G.G., Gordon K.E., Hill L.A., Chaplain M.A. Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model. J Theor Biol 2012, 308:1-9.
37. Dormann S., Deutsch A. Modeling of self-organized avascular tumor growth with a hybrid cellular automaton. In Silico Biology. 2002, 2(3):393-406.
38. Drasdo D. Center-based single-cell models: an approach to multi-cellular organization based on a conceptual analogy to colloidal particles. Single-cell-based models in biology and medicine 2007, 171-196. Springer.
39. Macklin P., Edgerton M.E., Thompson A.M., Cristini V. Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol 2012, 301:122-140.
40. Newman T.J. Modeling multicellular structures using the subcellular element model. Single-cell-based models in biology and medicine 2007, 221-239. Springer.
41. Glazier J.A., Balter A., Popławski N.J. Magnetization to morphogenesis: a brief history of the Glazier-Graner-Hogeweg model. Single-cell-based models in biology and medicine 2007, 79-106. Springer.
42. Rejniak K.A. An immersed boundary framework for modelling the growth of individual cells: an application to the early tumour development. J Theor Biol. 2007, 247(1):186-204.
43. Douglas R.M., Haddad G.G. Genetic models in applied physiology: invited review: effect of oxygen deprivation on cell cycle activity: a profile of delay and arrest. J Appl Physiol 2003, 94:2068-2083.
44. Schwartz G.K., Shah M.A. Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 2005, 23:9408-9421.
45. Garrett M.D., Fattaey A. CDK inhibition and cancer therapy. Curr Opin Genet Dev 1999, 9:104-111.
46. Goda N., Ryan H.E., Khadivi B., McNulty W., Rickert R.C., Johnson R.S. Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia. Mol Cell Biol 2003, 23:359-369.
47. Powathil G., Kohandel M., Milosevic M., Sivaloganathan S. Modeling the spatial distribution of chronic tumor hypoxia: implications for experimental and clinical studies. Comput Math Methods Med. 2012, 2012:410602.
48. Vaupel P. Oxygenation of human tumors. Strahlenther Onkol 1990, 166:377-386.
49. Pouyssegur J., Dayan F., Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437-443.
50. Bailar J.C., Gornik H.L. Cancer undefeated. N Engl J Med 1997, 336:1569-1574.
51. Shah M.A., Schwartz G.K. Cell cycle-mediated drug resistance: an emerging concept in cancer therapy. Clin Cancer Res 2001, 7:2168-2181.
52. Powathil G.G., Adamson D.J.A., Chaplain MAJ Towards predicting the response of a solid tumour to chemotherapy and radiotherapy treatments: clinical insights from a computational model. PLOS Comput Biol 2013, 9(7):e1003120.
53. Alper T., Howard-Flanders P. Role of oxygen in modifying the radiosensitivity of E. coli B. Nature. 1956, 178(4540):978-979.
54. Pawlik T.M., Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004, 59(4):928-942.
55. Wouters B.G., Brown J.M. Cells at intermediate oxygen levels can be more important than the "hypoxic fraction" in determining tumor response to fractionated radiotherapy. Radiat Res. 1997, 147(5):541-550.
56. Powathil G.G., Chaplain M.A.J., Swat M. Investigating the development of chemotherapeutic drug resistance in cancer: a multiscale computational study. IET Syst Biol 2014.
57. Swat M.H., Thomas G.L., Belmonte J.M., Shirinifard A., Hmeljak D., Glazier J.A. Multi-scale modeling of tissues using CompuCell3D. Methods Cell Biol. 2012, 110:325-366.
58. Maity A., McKenna W.G., Muschel R.J. The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol. 1994, 31(1):1-13.
59. Chaudhry M.A. Base excision repair of ionizing radiation-induced DNA damage in G1 and G2 cell cycle phases. Cancer Cell Int. 2007, 7:15.
60. Munro A.J. Bystander effects and their implications for clinical radiotherapy. J Radiol Prot. 2009, 29(2A):A133-142.